Susceptibility-guided vs. empirical 10-day quadruple treatment for Helicobacter pylori-infected patients: A prospective clinical trial of first-line therapy

BackgroundThe increasing antimicrobial resistance of Helicobacter pylori (H. pylori) has resulted in a fall in cure rates. We aimed to assess the effectiveness of first-line susceptibility-guided therapy and furazolidone-based quadruple therapy for H. pylori-infected patients.MethodsSubjects with H....

Full description

Bibliographic Details

Published in:	Frontiers in Microbiology
Main Authors:	Peiwei Li, Jing Jin, Yan Chen, Jianjuan Ma, Qin Du, Yuehua Han
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Subjects:	Helicobacter pylori eradication susceptibility-guided therapy empirical therapy randomized controlled trial
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2022.973975/full